Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Return on Assets (2022 - 2025)

Zentalis Pharmaceuticals has reported Return on Assets over the past 4 years, most recently at 0.44% for Q4 2025.

  • Quarterly results put Return on Assets at 0.44% for Q4 2025, down 7.0% from a year ago — trailing twelve months through Dec 2025 was 0.44% (down 7.0% YoY), and the annual figure for FY2025 was 0.38%, down 4.0%.
  • Return on Assets for Q4 2025 was 0.44% at Zentalis Pharmaceuticals, down from 0.44% in the prior quarter.
  • Over the last five years, Return on Assets for ZNTL hit a ceiling of 0.37% in Q1 2024 and a floor of 0.55% in Q1 2025.
  • Median Return on Assets over the past 4 years was 0.44% (2023), compared with a mean of 0.43%.
  • Biggest five-year swings in Return on Assets: increased 11bps in 2024 and later fell -18bps in 2025.
  • Zentalis Pharmaceuticals' Return on Assets stood at 0.41% in 2022, then dropped by -18bps to 0.49% in 2023, then rose by 22bps to 0.38% in 2024, then dropped by -18bps to 0.44% in 2025.
  • The last three reported values for Return on Assets were 0.44% (Q4 2025), 0.44% (Q3 2025), and 0.44% (Q2 2025) per Business Quant data.